Tiny study tests drug monitoring for scleroderma
NCT ID NCT04244916
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study aimed to see if monitoring the amount of a drug called mycophenolate mofetil in the blood could help improve skin tightness and lung function in people with systemic sclerosis. Only 2 people joined before the study was stopped early. The goal was to find the best drug level to guide treatment, but no conclusions could be drawn due to the small size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin hospital, AP-HP
Paris, France, 75014, France
Conditions
Explore the condition pages connected to this study.